Skip to main content

Table 2 Capacity of plasma concentrations of SAA to distinguish between patients who went on to develop an infection and those who did not

From: Proteomic discovery and verification of serum amyloid A as a predictor marker of patients at risk of post-stroke infection: a pilot study

Day

Number of patients

Mean SAA concentration (µg/mL) ± SD

ROC curve

No infection

Infection

No infection

Infection

p value

AUC (95% CI)

Cut-off

SP% (95% CI)

SE% (95% CI)

pAUC (95% CI)

SP 90–100% (95% CI)

0

19

21

16 ± 38.4

61.8 ± 96.7

0.01

73.2 (55.9–87)

14.2

84.2 (68.4–100)

61.9 (38.1–81)

2.53 (0–6.7)

24.7

94.7 (84.2–100)

42.9 (23.8–62.02)

1

19

17

28.2 ± 62.6

57.7 ± 92.9

0.005

77.1 (60.1–92)

8.8

63.2 (42.1–84.2)

88.2 (70.6–100)

2.3 (0.6–6.5)

133.4

94.7 (84.2–100)

35.3 (11.8–58.8)

3

19

21

27.6 ± 55.2

140.9 ± 136

0.001

80.7 (66.2–93.2)

21.4

84.2 (68.4–100)

71.4 (52.4–90.5)

3.6 (1.7–7.6)

233.9

100 (100–100)

33.3 (14.3–52.4)

5

19

21

33.6 ± 66.4

137 ± 123.5

0.003

76.7 (61.2–89.7)

87.8

94.7 (84.2–100)

57.1 (38.1–76.2)

3.5 (0.5–7.6)

87.8

94.7 (84.2–100)

57.1 (38.1–76.2)